Moody’s Downgrades Banks, Pharma Stocks Surge, UPS Cuts Forecast 8/8/23
Squawk on the Street
00:00
Novo Nordisk Rallying Reporting Better Than Expected Profit and Revenue
Novo Nordisk was up 16 pre-market after the company's anti-obesity drug, exceeded expectations in this late stage trial on this reduced risk of major cardiovascular events. This is big. We're talking about heart attack, obviously, for stroke and any number of other important implications. Not to mention this probably strengthens the case for payers, that is, the insurers- I thought so, Joe.
Play episode from 07:02
Transcript
